Why is the International Phase Important for Cancer Innovations?
The international phase allows cancer researchers to evaluate the patentability of their innovations before committing to the substantial costs associated with national phase entry. This is particularly beneficial in cancer research, where the development of new pharmaceutical products can be costly and time-consuming. The international phase provides a strategic advantage by allowing inventors to make informed decisions about patent protection in various markets.